Richter's popular drug receives reimbursement recommendation in Canada

Vrylar, jointly developed with US partner AbbVie, is the subject of the positive news

Hungary's Richter reports falling revenue and profit as FX no longer supportive

Results largely exceed analyst expectations, though

Hungary Richter delivers major upside surprise, reports robust Q3 figures

No one expected such a great performance

Hungary’s Richter extends licensing agreement with AbbVie

Cariprazine to be sold in more countries

ANALYST VIEW - Erste sharply raises target price for Hungary's Richter

Share price climbs to new all-time high

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

Hungary Richter to launch 'wonderdrug' on new market

Company signs exclusive license and supply agreement

Hungary's Richter expects cariprazine to drive growth

Not just in the U.S. but in Europe as well

Hungary Richter wonderdrug to be distributed in Asia

Mitsubishi Tanabe will distribute cariprazine in Thailand and Singapore.

Richter, Hikma sign exclusive license agreement for Cariprazine

Hikma will supply the antipsychotic drug in the MENA region.

Good news for Richter, share price jumps

Green-light by FDA warmly welcomed.

Hungary's Richter inks exclusive license deal for Australia, New Zealand

Richter to supply, Seqirus to sell.

Good news about flagship product of Hungary's Richter

Share price on the rise.

Richter drug wins 2017 Innovation Grand Prize in Hungary

Richter awarded for Cariprazine.

Hungary's Richter delivers bombastic news

Marketing of key drug green-lighted for Western Europe.

Fascinating news from Hungary's Richter

Key drug to hit shelves in Western Europe soon.

Bad news from Hungary's Richter on cariprazine effect

Good news by Hungary's Richter: key drug goes to Western Europe

Richter chief Bogsch discusses Q2 report

Hungary Richter has successful U.S. launch